360
Participants
Start Date
July 26, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
June 30, 2025
Catheter ablation
Delivery of physical energy from external energy source via percutaneously inserted electrophysiologic catheter to destroy heart tissue in the human atrium and adjoining vasculature
Rate or Rhythm control antiarrhythmic drugs for atrial fibrillation
Administration of antiarrhythmic drug to achieve either rate control or restoration of sinus rhythm for management of atrial fibrillation
Insertion of CardioMems Hemodynamic monitor
Insertion of wireless hemodynamic monitor to provide hemodynamic data to guide heart failure therapy to achieve heart failure improvement.
Empiric heart failure drug therapy
Administration of heart failure drug therapy based on clinical evaluation to achieve heart failure improvement.
RECRUITING
Hopitaux Universitaires de Geneve, Geneva
RECRUITING
Hospital of the University of Pennsylvania, Philadelphia
RECRUITING
Kansas City Heart Rhythm Institute, Overland
RECRUITING
St. Bernards Heart and Vascular Center, Jonesboro
RECRUITING
TCAI at St. David's Hospital, Austin
RECRUITING
South Denver Cardiology, Littleton
NOT_YET_RECRUITING
Peter Osypka Herzzentrum, Munich
RECRUITING
Northern Arizona Health Care, Flagstaff
RECRUITING
Electrophysiology Research Foundation, Warren Township
Electrophysiology Research Foundation
OTHER